Product
Dimenhydrinate
3 clinical trials
5 indications
Indication
VertigoIndication
PeripheralIndication
Perioperative OptimizationIndication
Gynecologic NeoplasmIndication
Healthy WomenClinical trial
" National, Phase III, Radomized, Double-Blind, Double -Dummy, Controlled, Parallel to Evaluate Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) Soft Gel Capsules in the Control of Acute Vertigo Symphtoms From Peripheral Origin"Status: Completed, Estimated PCD: 2017-04-01
Clinical trial
Randomized, Embedded, Multifactorial Adaptive Platform for Perioperative Medicine at UPMC (UPMC REMAP): Core Protocol - Enhanced Recovery Protocols (ERP)Status: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
The Effect of Dimenhydrinate on Postoperative Nausea and Vomiting After Abdominal Hysterectomy: Randomized-controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-25